Pharmaceutical drugs in the treatment of STEMI

dc.contributor.authorKer, James A.
dc.date.accessioned2016-09-02T08:00:19Z
dc.date.available2016-09-02T08:00:19Z
dc.date.issued2016-08
dc.description.abstractOur concept of ST-segment Elevated Myocardial Infarction (STEMI) refers to when coronary blood supply decreases abruptly after a thrombotic occlusion. The underlying mechanism leading to the thrombotic event is an unstable atherosclerotic plaque which ruptured (or cracked or eroded) exposing the content of the plaque to the blood initiating thrombogenesis.en_ZA
dc.description.departmentInternal Medicineen_ZA
dc.description.librarianam2016en_ZA
dc.description.urihttp://www.specialistforum.co.zaen_ZA
dc.identifier.citationKer, J 2016, 'Pharmaceutical drugs in the treatment of STEMI', The Specialist Forum, vol. 16, no. 7, pp. 20.en_ZA
dc.identifier.issn2218-8282
dc.identifier.urihttp://hdl.handle.net/2263/56589
dc.language.isoenen_ZA
dc.publisherNew Media Publishingen_ZA
dc.rights© The Specialist Forumen_ZA
dc.subjectThrombotic occlusionen_ZA
dc.subjectUnstable atherosclerotic plaqueen_ZA
dc.subjectCoronary blood supplyen_ZA
dc.subjectST-segment Elevated Myocardial Infarction (STEMI)en_ZA
dc.titlePharmaceutical drugs in the treatment of STEMIen_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Ker_Pharmaceutical_2016.pdf
Size:
176.37 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: